Concepedia

Linda J. Paradiso

LJ

Statistics

Publications

11

Citations

916

H-Index

11

Active since

1997

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Aberdeen

University of Minnesota

University of Southern California

Linda J. Paradiso is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, drug discovery, and pharmacotherapy.

Top concepts

Publications per year

1997–2019

11

Publications

11

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

Franco M. Muggia, John D. Hainsworth, Susan Jeffers et al. · Journal of Clinical Oncology · 1997 · 656 citations

Phase I and Pharmacokinetic Study of Prinomastat, a Matrix Metalloprotease Inhibitor

Kenneth R. Hande, Mary Collier, Linda J. Paradiso et al. · Clinical Cancer Research · 2004 · 51 citations · Full text

Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034.

Howard L. McLeod, J Cassidy, Robert H. Powrie et al. · PubMed · 2000 · 37 citations

, , +13

Circulating Mononuclear Progenitor Cells: Differential Roles for Subpopulations in Repair of Retinal Vascular Injury

Sergio Caballero, Sugata Hazra, Ashay D. Bhatwadekar et al. · Investigative Ophthalmology & Visual Science · 2013 · 28 citations · Full text

Brain Distribution of a Novel MEK Inhibitor E6201: Implications in the Treatment of Melanoma Brain Metastases

Gautham Gampa, Minjee Kim, Nicholas Cook-Rostie et al. · Drug Metabolism and Disposition · 2018 · 28 citations · Full text

1–5 of 11